Hui Kong
- Molecular Biology
- Immunology
- Cancer Research top 10%
- Oncology
- Cell Biology top 10%
- Topics
- Osteoarthritis Treatment and Mechanisms (7 papers)Connexins and lens biology (4 papers)RNA modifications and cancer (4 papers)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Hui Kong
54 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 125
- Molecular Biology 580
- Immunology 206
- Cancer Research 174
- Oncology 171
- Cell Biology 135
Countries citing papers authored by Hui Kong
This map shows the geographic impact of Hui Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Kong more than expected).
Fields of papers citing papers by Hui Kong
This network shows the impact of papers produced by Hui Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Kong. The network helps show where Hui Kong may publish in the future.
Co-authorship network of co-authors of Hui Kong
This figure shows the co-authorship network connecting the top 25 collaborators of Hui Kong. A scholar is included among the top collaborators of Hui Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Kong. Hui Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 3 | |
| 3 | 0 | |
| 4 | 6 | |
| 5 | 1 | |
| 6 | 3 | |
| 7 | 2 | |
| 8 | 30 | |
| 9 | 20 | |
| 10 | 9 | |
| 11 | 15 | |
| 12 | 15 | |
| 13 | 49 | |
| 14 | 27 | |
| 15 | 16 | |
| 16 | 1 | |
| 17 | 54 | |
| 18 | 60 | |
| 19 | 46 | |
| 20 | 34 |
About Hui Kong
Hui Kong is a scholar working on Rheumatology, Clinical Biochemistry and Physiology, having authored 60 papers that have together received 1.2k indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (7 papers), Connexins and lens biology (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (174 citations), Immunology (206 citations) and Molecular Biology (580 citations). Hui Kong has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Xinan Zhang, Xue‐Qiang Wang, Gang Hu, Xiu‐Lan Sun, Juanjuan Han, Zhugang Wang, Li Kong, Xuesong Liu, Xiang Ren and Mingli Sun. Their work appears in journals such as Blood, Journal of Cleaner Production and Food Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.